Impact of 80 W KTP Laser Vaporization Prostatectomy on Severity of Obstruction in Benign Prostatic Hyperplasia
Study Details
Study Description
Brief Summary
The purpose of this study is to compared the efficacy of 80W KTP photoselective laser vaporization prostatectomy (PVP) and transurethral resection of the prostate (TURP) in reducing the volume of prostate and relieving the obstruction in men with benign prostatic hyperplasia (BPH) on non-randomized controlled design.
Condition or Disease | Intervention/Treatment | Phase |
---|---|---|
|
N/A |
Study Design
Arms and Interventions
Arm | Intervention/Treatment |
---|---|
Active Comparator: 1 PVP group |
Procedure: photoselective vaporization prostatectomy (PVP)
PVP using 80 W KTP laser with a Greenlight system (GreenLight PVTM, Laserscope®, San Jose, CA)
Other Names:
|
Active Comparator: 2 TURP group |
Procedure: Transurethral resection of the prostate
Standard transurethral resection of the prostate using electrocautery loop
Other Names:
|
Outcome Measures
Primary Outcome Measures
- The changes of bladder outlet obstruction index (BOOI) [6months]
Secondary Outcome Measures
- The changes of Quality of Life (QoL) parameters [6, 12 months]
- The changes of Uroflowmetry (UFM) and Postvoid residual urine(PVR) [6, 12 months]
- The changes of detrusor pressure at maximum flow rate (PdetQmax)parameters [6months]
- The changes of International Prostatic Symptom Scores (IPSS) [6, 12 months]
- The changes of Schafer obstruction grade parameters [6months]
- The changes of prostate volume [6, 12 months]
- postoperative catheterization days [immediate postoperative period]
- Complications [During all study periods]
- The changes of the hemoglobin and the serum sodium and the serum PSA [immediate postoperative period]
- The change of IIEF score [6, 12 months]
Eligibility Criteria
Criteria
Inclusion Criteria:
-
Symptomatic BPH
-
International Score Prostate Symptom (IPSS) of 13 or greater
-
prostate volume of 30 to 100 ML
-
Peak urinary flow rate (Qmax) less than 15 mL/s with a voided volume of >125 mL and a PVR <350mL
-
Able to give fully informed consent
Exclusion Criteria:
-
Subjects with histological diagnosis of prostate cancer
-
Subjects with history of chronic urinary retention
-
Subjects with urethral stricture,
-
Subjects with bladder neck contracture
-
Subjects with urinary tract infection
-
Subjects with prostate volume on TRUS of >100 mL
-
Subjects with suspected neurogenic bladder dysfunction
-
Subjects who, in the opinion of investigator, are not likely to complete the study for whatever reason
Contacts and Locations
Locations
Site | City | State | Country | Postal Code | |
---|---|---|---|---|---|
1 | Samsung Medical Center | Seoul | Korea, Republic of |
Sponsors and Collaborators
- Samsung Medical Center
Investigators
- Principal Investigator: Sung-Won Lee, Ph.D.,M.D., Samsung Medical Center
Study Documents (Full-Text)
None provided.More Information
Publications
None provided.- 2004-05-09